8. STOCK-BASED COMPENSATION

The Company’s stockholders approved amendments to the 2013 Plan to increase the authorized number of shares of Common Stock available and reserved for issuance under the 2013 Plan by 20,000,000 shares on May 27, 2025, and an additional 6,100,000 shares on May 22, 2026.

Under the 2013 Plan, the Company may grant awards of stock options, stock appreciation rights, restricted stock awards, RSUs, unrestricted stock, dividend equivalent rights, performance shares and other performance-based awards, other equity-based awards and cash bonus awards to eligible persons. Equity awards under the 2013 Plan are granted from time to time at the discretion of the Compensation Committee of the Board (the “Committee”), with vesting periods and other terms as determined by the Committee with a maximum term of 10 years. The 2013 Plan is administered by the Committee, which can delegate the administration to the Board, other committees or to such other officers and employees of the Company as designated by the Committee and permitted by the 2013 Plan. As of June 30, 2026, 730,057 shares were available for future issuances under the 2013 Plan.  

The Inducement Plan provides for the grant of equity-based awards, including RSUs, restricted stock, performance shares and performance units. Under the Inducement Plan, the Company may grant equity awards for the sole purpose of recruiting and hiring new employees. The Board approved an amendment to the Inducement Plan to increase the authorized number of shares of Common Stock available and reserved for issuance under the Inducement Plan by 385,571 shares on May 22, 2026.  As of June 30, 2026, 500,000 shares of Common Stock were available for future issuances under the Inducement Plan.

For the three and six months ended June 30, 2026, the Company recorded stock-based compensation expense of approximately $1.0 million and $1.6 million, respectively.  For the three and six months ended June 30, 2025, the Company recorded stock-based compensation expense of approximately $0.8 million and $0.9 million, respectively.  Stock compensation expense is recorded in the “General and administrative expenses” line item within the Condensed Consolidated Statements of Operations.

Stock Options

​

The following table summarizes stock options outstanding for the six months ended June 30, 2026 and 2025:

​

​

All options outstanding for the six months ended June 30, 2026, were issued and vested under the 2013 Plan.  The weighted average remaining term for stock options outstanding as of June 30, 2026, is approximately 5.3 years.

​

As of June 30, 2026, the Company had no unrecognized compensation costs related to non-vested stock options.

​

Restricted Stock Units

The following table summarizes RSU activity for the six months ended June 30, 2026 and 2025:

​

​

Forfeited/Expired shares are those RSU awards that either were forfeited by the holder, or RSU awards that did not vest due to certain vesting criteria not being met.  The increase in RSU activity as of June 30, 2026 as compared to  June 30, 2025 is due to the larger and more broadly distributed RSU awards granted in May 2025 and May 2026 compared to prior years.

As of June 30, 2026, the Company had approximately $5.0 million of unrecognized compensation costs related to non-vested RSUs that will be recognized over a period of approximately 2.5 years.